Northern Africa and Western Asia vs Sweden: Proportion of the target population who received a 3rd dose of
Northern Africa and Western Asia
50.0%
in 2024
Sweden
94.0%
in 2024
Northern Africa and Western Asia rank
33rd
Sweden rank
36th
Proportion of the target population who received a 3rd dose of over time
- Northern Africa and Western Asia
- Sweden
How they compare
Sweden currently reports 94.0% against 50.0% in Northern Africa and Western Asia, a difference of 44.0%.
That makes Sweden's figure about 1.9 times Northern Africa and Western Asia's.
Across all 17 years both countries report, Sweden has been ahead every year.
Northern Africa and Western Asia ranks 33rd and Sweden ranks 36th of 37 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Northern Africa and Western Asia | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.5% | 79.0% | 70.5% | Sweden |
| 2010s | 41.7% | 97.5% | 55.8% | Sweden |
| 2020s | 50.6% | 95.2% | 44.6% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Northern Africa and Western Asia or Sweden?
- Sweden, at 94.0% against 50.0% in Northern Africa and Western Asia as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Northern Africa and Western Asia and Sweden?
- 44.0%, with Sweden ahead.
- How many years of comparable data are there for Northern Africa and Western Asia and Sweden?
- 17 years are reported by both, from 2008 to 2024.
- How do Northern Africa and Western Asia and Sweden rank globally for proportion of the target population who received a 3rd dose of?
- Northern Africa and Western Asia ranks 33rd and Sweden ranks 36th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.